Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Development of Direct Intra-Bone Marrow Gene Transfer of Lentiviral Vectors Containing a B-Domain Variant of Human Factor VIII for Hemophilia A Treatment

Xuefeng Wang, Liping Chen, Peiqing Ye, Andy Chiang, Carol H. Miao, PhD

Blood (2011) 118 (21): 4710.

https://doi.org/10.1182/blood.V118.21.4710.4710

Published: 2011

Journal Articles

In Vivo Expansion of Treg Cells Prevents Anti-FVIII Antibody Production Following FVIII Protein Replacement Therapy in Hemophilia A Mice

Chao-Lien Liu, Peiqing Ye, Jaqueline Lin, Carol H. Miao, PhD

Blood (2011) 118 (21): 23.

https://doi.org/10.1182/blood.V118.21.23.23

Published: 2011

Journal Articles

Anti-CD3 antibodies modulate anti–factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy

Baowei Peng, Peiqing Ye, David J. Rawlings, Hans D. Ochs, Carol H. Miao

Blood (2009) 114 (20): 4373–4382.

https://doi.org/10.1182/blood-2009-05-217315

Published: 2009

Includes: Supplemental data

Journal Articles

Reduction of Inhibitory Anti-FVIII Antibody Titer by Using a B Domain Variant FVIII/N6 cDNA for Nonviral Gene Therapy in Hemophilia a Mice

Dominika Jirovska, Peiqing Ye, Steven W. Pipe, MD, Carol H. Miao, PhD

Blood (2008) 112 (11): 3537.

https://doi.org/10.1182/blood.V112.11.3537.3537

Published: 2008

Journal Articles

Engineered Factor IX with Augmented Clotting Activities in a Hemophilia B Mouse Model.

Chia-Ni Lin, Chung-Yang Kao, Chia-Lun Hong, Peiqing Ye, Carol H. Miao, PhD, Nobuko Hamaguchi, Hua-Lin Wu, Guey-Yueh Shi, Yung-Li Yang, I-Shing Yu, Mi-Hua Tao, Cheng-Chieh Fang, Yi-Lin Liu, Katherine A. High, MD, Shu-Wha Lin

Blood (2008) 112 (11): 2025.

https://doi.org/10.1182/blood.V112.11.2025.2025

Published: 2008

Journal Articles

Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice

Baowei Peng, Peiqing Ye, Bruce R. Blazar, Gordon J. Freeman, David J. Rawlings, Hans D. Ochs, Carol H. Miao

Blood (2008) 112 (5): 1662–1672.

https://doi.org/10.1182/blood-2008-01-128413

Published: 2008

Journal Articles

Transient Blockade of ICOS Co-Stimulatory Pathways Induces Long-Term Tolerance to Factor VIII Following Nonviral Gene Transfer of Factor VIII Plasmid into Hemophilia A Mice.

Baowei Peng, PhD, Peiqing Ye, MD, Bruce R. Blazer, MD, Hans D. Ochs, MD, MSc, Carol H. Miao, PhD

Blood (2006) 108 (11): 3283.

https://doi.org/10.1182/blood.V108.11.3283.3283

Published: 2006

Journal Articles

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice

Carol H. Miao, Peiqing Ye, Arthur R. Thompson, David J. Rawlings, Hans D. Ochs

Blood (2006) 108 (1): 19–27.

https://doi.org/10.1182/blood-2005-11-4532

Published: 2006

Journal Articles

Immunomodulation of Transgene Responses Following Naked DNA Transfer of Factor VIII into Hemophilia A Mice.

Peiqing Ye, MD, David J. Rawlings, MD, Arthur R. Thompson, MD, PhD, Hans D. Ochs, MD,Dr.Med, Carol H. Miao, PhD

Blood (2005) 106 (11): 1279.

https://doi.org/10.1182/blood.V106.11.1279.1279

Published: 2005

Journal Articles

Efficacy of Zymogen Factor VII Is Comparable to Activated Factor VII for Nonviral Gene Therapy Treatment of Hemophilia A.

Steven C. Chen, BS, Daniel Greenberg, MD, Peiqing Ye, MD, Earl W. Davie, PhD, Carol H. Miao, PhD

Blood (2005) 106 (11): 5543.

https://doi.org/10.1182/blood.V106.11.5543.5543

Published: 2005

Journal Articles

Dependence of Vector Dose and Age of Mice in the Induction of Immune Response Against Factor VIII Following Liver-Directed Nonviral Gene Transfer.

Peiqing Ye, MD, Carol H. Miao, PhD

Blood (2004) 104 (11): 3186.

https://doi.org/10.1182/blood.V104.11.3186.3186

Published: 2004

NARROW

Development of Direct Intra-Bone Marrow Gene Transfer of Lentiviral Vectors Containing a B-Domain Variant of Human Factor VIII for Hemophilia A Treatment

In Vivo Expansion of Treg Cells Prevents Anti-FVIII Antibody Production Following FVIII Protein Replacement Therapy in Hemophilia A Mice

Anti-CD3 antibodies modulate anti–factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy

Reduction of Inhibitory Anti-FVIII Antibody Titer by Using a B Domain Variant FVIII/N6 cDNA for Nonviral Gene Therapy in Hemophilia a Mice

Engineered Factor IX with Augmented Clotting Activities in a Hemophilia B Mouse Model.

Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice

Transient Blockade of ICOS Co-Stimulatory Pathways Induces Long-Term Tolerance to Factor VIII Following Nonviral Gene Transfer of Factor VIII Plasmid into Hemophilia A Mice.

Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice

Immunomodulation of Transgene Responses Following Naked DNA Transfer of Factor VIII into Hemophilia A Mice.

Efficacy of Zymogen Factor VII Is Comparable to Activated Factor VII for Nonviral Gene Therapy Treatment of Hemophilia A.

Dependence of Vector Dose and Age of Mice in the Induction of Immune Response Against Factor VIII Following Liver-Directed Nonviral Gene Transfer.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only